Zeleciment rostudirsen (DYNE-251)
Dyne Therapeutics (DYN)
Decision dateJan 21, 2027
67 days away
Marketer take
Another DMD decision close to Deramiocel's, so DMD brand and advocacy teams face a busy, crowded news cycle.
- Sponsor company
- Dyne Therapeutics (DYN)
- Indication
- Duchenne muscular dystrophy (DMD)
- Therapeutic area
- Neurology, Rare disease
- Event
- PDUFA target action date
- Date
- Jan 21, 2027
- Status
- Upcoming
- Source
- company press release
- Last verified
- Nov 15, 2026
Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?